Cargando…

Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options

Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced se...

Descripción completa

Detalles Bibliográficos
Autores principales: Younis, Hazar, Ha, Se Eun, Jorgensen, Brian G., Verma, Arushi, Ro, Seungil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697644/
https://www.ncbi.nlm.nih.gov/pubmed/36573710
http://dx.doi.org/10.3390/jpm12111762
_version_ 1784838617501270016
author Younis, Hazar
Ha, Se Eun
Jorgensen, Brian G.
Verma, Arushi
Ro, Seungil
author_facet Younis, Hazar
Ha, Se Eun
Jorgensen, Brian G.
Verma, Arushi
Ro, Seungil
author_sort Younis, Hazar
collection PubMed
description Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced secretion of insulin, and hyperglycemia. Presently, 14 MODY subtypes have been identified. Within these subtypes are several mutations which contribute to the different MODY phenotypes. Despite the identification of these 14 subtypes, MODY is often misdiagnosed as type 1 or type 2 diabetes mellitus due to an overlap in clinical features, high cost and limited availability of genetic testing, and unfamiliarity with MODY outside of the medical profession. The primary aim of this review is to investigate the genetic characterization of the MODY subtypes. Additionally, this review will elucidate the link between the genetics, function, and clinical manifestations of MODY in each of the 14 subtypes. In providing this knowledge, we hope to assist in the accurate diagnosis of MODY patients and, subsequently, in ensuring they receive appropriate treatment.
format Online
Article
Text
id pubmed-9697644
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96976442022-11-26 Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options Younis, Hazar Ha, Se Eun Jorgensen, Brian G. Verma, Arushi Ro, Seungil J Pers Med Review Maturity-Onset Diabetes of the Young (MODY) is a rare form of diabetes which affects between 1% and 5% of diagnosed diabetes cases. Clinical characterizations of MODY include onset of diabetes at an early age (before the age of 30), autosomal dominant inheritance pattern, impaired glucose-induced secretion of insulin, and hyperglycemia. Presently, 14 MODY subtypes have been identified. Within these subtypes are several mutations which contribute to the different MODY phenotypes. Despite the identification of these 14 subtypes, MODY is often misdiagnosed as type 1 or type 2 diabetes mellitus due to an overlap in clinical features, high cost and limited availability of genetic testing, and unfamiliarity with MODY outside of the medical profession. The primary aim of this review is to investigate the genetic characterization of the MODY subtypes. Additionally, this review will elucidate the link between the genetics, function, and clinical manifestations of MODY in each of the 14 subtypes. In providing this knowledge, we hope to assist in the accurate diagnosis of MODY patients and, subsequently, in ensuring they receive appropriate treatment. MDPI 2022-10-25 /pmc/articles/PMC9697644/ /pubmed/36573710 http://dx.doi.org/10.3390/jpm12111762 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Younis, Hazar
Ha, Se Eun
Jorgensen, Brian G.
Verma, Arushi
Ro, Seungil
Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title_full Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title_fullStr Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title_full_unstemmed Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title_short Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options
title_sort maturity-onset diabetes of the young: mutations, physiological consequences, and treatment options
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697644/
https://www.ncbi.nlm.nih.gov/pubmed/36573710
http://dx.doi.org/10.3390/jpm12111762
work_keys_str_mv AT younishazar maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions
AT haseeun maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions
AT jorgensenbriang maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions
AT vermaarushi maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions
AT roseungil maturityonsetdiabetesoftheyoungmutationsphysiologicalconsequencesandtreatmentoptions